ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

EBS Emergent Biosolutions Inc

1.9001
-0.0499 (-2.56%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 880,929
Bid Price
Ask Price
News -
Day High 2.01

Low
1.42

52 Week Range

High
10.8799

Day Low 1.90
Company Name Stock Ticker Symbol Market Type
Emergent Biosolutions Inc EBS NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0499 -2.56% 1.9001 19:58:23
Open Price Low Price High Price Close Price Prev Close
2.00 1.90 2.01 1.92 1.95
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,248 880,929 $ 1.94 $ 1,712,804 - 1.42 - 10.8799
Last Trade Time Type Quantity Stock Price Currency
19:59:56 formt 1,800 $ 1.9001 USD

Emergent Biosolutions Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
100.23M 52.20M - 1.05B -760.5M -14.57 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Emergent Biosolutions News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EBS Message Board. Create One! See More Posts on EBS Message Board See More Message Board Posts

Historical EBS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.842.361.842.121,012,7850.06013.27%
1 Month2.552.60561.82012.141,007,922-0.6499-25.49%
3 Months1.663.7251.422.593,164,8100.240114.46%
6 Months2.133.7251.422.462,183,109-0.2299-10.79%
1 Year9.4810.87991.424.012,039,190-7.58-79.96%
3 Years62.0068.02811.4216.041,246,383-60.10-96.94%
5 Years54.00137.611.4230.71973,914-52.10-96.48%

Emergent Biosolutions Description

Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products.

Your Recent History

Delayed Upgrade Clock